Abstract:Objective: With the deepening of magnetic biomedical effects and electromagnetic technology, some medical instruments based on static magnetic field (SMF) have been used in orthopedic-related diseases treatment. Studies have shown SMF could combat osteoporosis by regulating the differentiation of mesenchymal stem cells (MSCs), osteoblast and osteoclast. With the development of nanotechnology, iron oxide nanoparticles (IONPs) have been reported to regulate the process of bone anabolism. As for SMF combined with IONPs, studies indicated osteo-genic differentiation of MSCs were promoted by the combination of SMF and IONPs. However, there are few reports on the effects of SMF combined with IONPs on osteoclast. Herein, the purpose of this study was to investigate the effects of high static magnetic field (HiSMF) combined with IONPs on unloading-induced bone loss in vivo and osteoclastic formation in vitro, and elucidated the potential molecular mechanisms.Methods: In vivo, C57BL/6 J male mice were unloaded via tail suspension or housed normally. The hindlimb of mice were fixed and exposed to 1-2 T SMF for 1 h every day, 10 mg/kg of Ferumoxytol or saline were injected by tail vein once a week, last for 4 weeks. Bone microstructure, mechanical properties, and osteoclastogenesis were examined respectively. In vitro, the RAW264.7 cells were used to assess the effects of 1-2 T SMF combined with IONPs in osteoclastogenesis. The iron content was detected by atomic absorption spectrometry and Prussian blue staining. DCFH-DA and MitoSOXTM fluorescence staining were used to assess oxidative stress levels. NF-Kappa B and MAPK signaling pathways were examined by western blot assay.Results: In vivo, the results showed 1-2 T SMF and IONPs prevented the damage to bone microstructure and improved the mechanical properties, diminished the number of osteoclasts in unloaded mice, 1-2 T SMF com-bined with IONPs was found more effective. The iron content in the liver and spleen was reduced by the com-bination of 1-2 T SMF and IONPs, enhancing iron levels in the femur. In vitro, osteoclast formation was inhibited by 1-2 T SMF and IONPs treatment, and 1-2 T SMF combined with IONPs had a more pronounced effect. Moreover, iron uptake of IONPs in osteoclast was reduced to 1-2 T SMF exposure. Oxidative stress levels were decreased in osteoclast differentiation under 1-2 T SMF combined with IONPs treatment. Molecularly, the expression of NF-Kappa B and MAPK signaling pathways were inhibited under 1-2 T SMF combined with IONPs in osteoclastogenesis.Conclusions: Synthetically, our research illustrated 1-2 T SMF combined with IONPs prevented unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis.Translational potential of this article: As a non-invasive alternative therapy, some medical instruments based on SMF have been used for orthopedic-related diseases treatment for their portability, cheapness and safety. Ferumoxytol (FerahemeTM), the first FDA-approved IONP drug for the treatment of iron deficiency anemia, has been also adapted in translational research for osteoporosis. Based on the above-mentioned two points, we found the synergistic effects of SMF and Ferumoxytol for treatment of experimental osteoporosis. These results show translational potentials for clinical application.

Nitric Oxide Modulates the Responses of Osteoclast Formation to Static Magnetic Fields.

Regulation of Osteoclast Differentiation by Static Magnetic Fields

16 T High Static Magnetic Field Inhibits Receptor Activator Of Nuclear Factor Kappa-Beta Ligand-Induced Osteoclast Differentiation By Regulating Iron Metabolism In Raw264.7 Cells

Regulation of Osteoblast Differentiation and Iron Content in MC3T3-E1 Cells by Static Magnetic Field with Different Intensities

[Nitric Oxide Regulates C-Fos Expression in Osteoblastic Cells Induced by Wall-Shear].

Transcriptome Analysis Reveals the Negative Effect of 16 T High Static Magnetic Field on Osteoclastogenesis of RAW264.7 Cells

Alterations of Mineral Elements in Osteoblast During Differentiation Under Hypo, Moderate and High Static Magnetic Fields

Effect of High Static Magnetic Fields on Biological Activities and Iron Metabolism in MLO-Y4 Osteocyte-like Cells

MiR-466d Targeting MMP13 Promotes the Differentiation of Osteoblasts Exposed to a Static Magnetic Field

Magneto-mechanical Stimulation Modulates Osteocyte Fate Via the ECM-integrin-CSK Axis and Wnt Pathway

Diamagnetic Levitation Promotes Osteoclast Differentiation from RAW264.7 Cells

低酸素刺激による破骨細胞分化促進は一酸化窒素合成経路の活性化を介する

Iron Oxide Nanoparticles Combined with Static Magnetic Fields in Bone Remodeling

Effects of Static Magnetic Fields on Bone Microstructure and Mechanical Properties in Mice.

Nitric oxide contributes to rapid sclerostin protein loss following mechanical load

Static Magnetic Field (2-4 T) Improves Bone Microstructure and Mechanical Properties by Coordinating Osteoblast/Osteoclast Differentiation in Mice

Moderate SMFs attenuate bone loss in mice by promoting directional osteogenic differentiation of BMSCs

1–2 T Static Magnetic Field Combined with Ferumoxytol Prevent Unloading-Induced Bone Loss by Regulating Iron Metabolism in Osteoclastogenesis

Large gradient high magnetic fields affect osteoblast ultrastructure and function by disrupting collagen I or fibronectin/αβ1 integrin.

Synergistic Osteogenesis Promoted by Magnetically Actuated Nano-Mechanical Stimuli

The Response to High Magneto-Gravitational Environment of Different Differentiating-Stage Osteoblasts